Chemical industry – Page 91
-
Business
Court overturns approval to grow GM potato in Europe
Europe’s second highest court rules that European commission did not follow its own rules when giving Amflora the green light
-
Business
Honeywell invests $300m in green refrigerant
New manufacturing plant will produce a gas for car air conditioners that has a much lower global warming potential
-
BusinessLanzatech expands waste-to-chemicals range
Partnership with Evonik will see gas-guzzling microbes make polymer precursors
-
Business
Dow shakes out chlorine business
Company will divest low-margin segments to improve efficiency and focus on higher value specialities
-
Business
Merck KGaA snaps up electronic materials specialist
Firm looks to bolster R&D by acquiring AZ Electronic Materials
-
BusinessNike eliminates water at new Taiwanese dyeing plant
ColorDry process uses supercritical CO2 to reduce waste and cut costs
-
BusinessNew wave of hepatitis C drugs hits US shore
J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
-
Business
US turnaround on Avandia restrictions
Researchers accuse regulator of face-saving U-turn over diabetes medication safety
-
Opinion
Unwelcome festive offerings
It’s not easy to learn you’re going to lose your job, especially at this time of year
-
OpinionPut the chemistry back in medicinal chemistry
Pursuing skewed priorities and easy options has impoverished the pharmaceutical industry, says David Lathbury.
-
OpinionRolling boulders uphill
Is Derek Lowe troubled by his failure to develop a compound that has made it to the pharmacy shelf?
-
BusinessReach is a big trade barrier, say US manufacturers
Europe says requirements for US companies are the same as for EU competitors
-
FeatureFarming tomorrow
Technology is helping farmers better control the use of fertilisers and pesticides, as Elisabeth Jeffries reports
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
FeatureGeneric problems
The Indian pharmaceutical industry has been hit by recent problems. Angeli Mehta investigates
-
Business
DSM to spin out pharma unit
Firm will combine with Patheon to provide manufacturing services
-
BusinessRapid DNA sequencing cleared for the clinic
Illumina’s ‘next-generation’ MiSeqDx platform gets US approval
-
Business
Novartis sells off blood diagnostics division
$1.7bn deal reinforces firm’s focus on core pharmaceuticals